Medicare Enrolled
Dr. Mayer Rashtian, M.D.
Cardiovascular Disease · Pasadena, CA
Practice pattern: Remote & Electrophysiology
— Practice combining remote and electrophysiology services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rashtian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rashtian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rashtian
Dr. Mayer Rashtian is a cardiovascular disease specialist in Pasadena, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rashtian performed 9,835 Medicare services across 5,583 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rashtian received a total of $220,798 from 61 pharmaceutical and/or device companies across 1577 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rashtian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 7% volume in CA
$220,798 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,835
Medicare services
Top 7% in CA for cardiovascular disease
5,583
Unique beneficiaries
$112
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~518 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
1,040 | $47 | $223 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
924 | $105 | $250 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
914 | $12 | $80 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
687 | $43 | $170 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
684 | $7 | $61 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
616 | $22 | $100 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
512 | $35 | $135 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
494 | $21 | $85 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
489 | $800 | $1,200 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
439 | $22 | $87 |
| Psychiatric collaborative care follow-up, first 60 minutes A follow-up psychiatric care management visit for subsequent calendar months. The service covers the first 60 minutes of collaborative care coordination. |
408 | $125 | $511 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
360 | $25 | $125 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
205 | $150 | $350 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
203 | $31 | $225 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
184 | $15 | $154 |
| 2-day continuous ECG monitoring A continuous electrocardiogram recording that captures heart activity over a 48-hour period. This test helps detect irregular heart rhythms or other cardiac issues that may not appear during a standard, short-term ECG. |
180 | $16 | $160 |
| Psychiatric collaborative care management, additional 30 minutes This code covers each additional 30 minutes of psychiatric collaborative care management provided per calendar month. |
156 | $51 | $195 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
153 | $102 | $325 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
111 | $68 | $263 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
100 | $61 | $190 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
70 | $55 | $200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
68 | $131 | $425 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
65 | $13 | $55 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
65 | $149 | $600 |
| Cardiac rhythm monitor evaluation Review and analysis of data recorded by a cardiac rhythm monitoring device to assess heart activity. |
57 | $44 | $150 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
55 | $94 | $345 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
54 | $70 | $175 |
| Repair of left upper heart chamber with implant A surgical procedure to repair the left upper chamber of the heart using an implanted device, with review by a radiologist. |
51 | $405 | $1,610 |
| Insertion of implantable heart rhythm monitor A small device is placed under the skin to continuously record the heart's electrical activity. This helps detect irregular heart rhythms that may not appear during a standard office visit. |
47 | $4,183 | $12,300 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
46 | $18 | $67 |
| Permanent leadless pacemaker insertion A small, self-contained pacemaker is placed directly into the heart without using wires. The procedure is guided by imaging to ensure correct positioning. |
39 | $380 | $1,605 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
36 | $53 | $126 |
| Psychiatric collaborative care management, first 30 minutes This service involves behavioral health manager activities coordinated with a psychiatric consultant and directed by the treating physician. It covers the initial or subsequent care management for the first 30 minutes within a month. |
32 | $51 | $216 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
29 | $90 | $475 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
29 | $18 | $125 |
| Initial psychiatric collaborative care management, first 70 minutes This service covers the first 70 minutes of psychiatric collaborative care management during the initial calendar month of treatment. |
29 | $135 | $513 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
28 | $84 | $295 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
28 | $68 | $225 |
| Radiofrequency ablation for supraventricular tachycardia A procedure to locate and destroy abnormal heart tissue in the upper chambers of the heart that causes a rapid heart rate. |
27 | $671 | $2,500 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
26 | $70 | $225 |
| Ultrasound of heart blood vessels with radiologist review An ultrasound exam that evaluates blood vessels within the heart, including a review of the results by a radiologist. |
25 | $64 | $500 |
| New patient office visit, complex (60-74 min) | 22 | $193 | $500 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
20 | $118 | $430 |
| Atrial fibrillation ablation with pulmonary vein isolation A procedure to treat atrial fibrillation by mapping the heart's electrical activity and destroying tissue causing irregular contractions. This is done by isolating the pulmonary veins using catheter-based destruction. |
15 | $790 | $3,500 |
| Cardiac rhythm monitor programming Adjustment and configuration of an implanted cardiac rhythm monitoring device to ensure proper operation and data collection. |
13 | $22 | $210 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.8% high complexity
0.3% medium
89.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$220,798
Total received (2018-2024)
Avg $31,543/year across 7 years
Top 3% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
1,577
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$110,217 (49.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$70,734 (32.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$39,846 (18.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$18,039
2023
$19,354
2022
$39,552
2021
$55,226
2020
$18,603
2019
$43,500
2018
$26,524
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
SANOFI-AVENTIS U.S. LLC
$5,166
Abbott Laboratories
$4,524
CARDIVA MEDICAL, INC.
$2,241
Boston Scientific Corporation
$1,865
Janssen Pharmaceuticals, Inc
$1,718
Medtronic, Inc.
$425
PFIZER INC.
$367
Lexicon Pharmaceuticals, Inc.
$294
Boehringer Ingelheim Pharmaceuticals, Inc.
$233
Merck Sharp & Dohme LLC
$160
Novartis Pharmaceuticals Corporation
$148
E.R. Squibb & Sons, L.L.C.
$144
ATRICURE, INC.
$108
Philips North America LLC
$105
Lilly USA, LLC
$73
Kiniksa Pharmaceuticals International, plc
$68
Alnylam Pharmaceuticals Inc.
$59
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$59
Novo Nordisk Inc
$43
Celgene Corporation
$41
Bayer Healthcare Pharmaceuticals Inc.
$37
Edwards Lifesciences Corporation
$32
AstraZeneca Pharmaceuticals LP
$29
Impulse Dynamics (USA) Inc.
$27
Amgen Inc.
$20
Actelion Pharmaceuticals US, Inc.
$19
Kestra Medical Technology Services, Inc.
$17
HEARTFLOW, INC.
$15
Top 3 companies account for 66.1% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$77,316
Janssen Pharmaceuticals, Inc
$53,669
SANOFI-AVENTIS U.S. LLC
$29,839
E.R. Squibb & Sons, L.L.C.
$22,764
Boston Scientific Corporation
$9,850
PFIZER INC.
$6,100
CARDIVA MEDICAL, INC.
$5,145
Medtronic, Inc.
$2,070
Novartis Pharmaceuticals Corporation
$2,060
BOSTON SCIENTIFIC CORPORATION
$1,438
Amgen Inc.
$1,319
Boehringer Ingelheim Pharmaceuticals, Inc.
$839
Medtronic Vascular, Inc.
$747
Medical Device Business Services, Inc.
$660
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$659
AstraZeneca Pharmaceuticals LP
$525
Lexicon Pharmaceuticals, Inc.
$463
BAXTER HEALTHCARE
$390
AtriCure, Inc.
$349
Alnylam Pharmaceuticals Inc.
$329
Actelion Pharmaceuticals US, Inc.
$318
Merck Sharp & Dohme LLC
$313
Impulse Dynamics (USA) Inc.
$312
Acutus Medical, Inc.
$300
Esperion Therapeutics, Inc.
$254
Edwards Lifesciences Corporation
$194
Gilead Sciences, Inc.
$177
ZOLL Respicardia, Inc.
$157
Philips Electronics North America Corporation
$157
Kiniksa Pharmaceuticals, Ltd.
$156
Amarin Pharma Inc.
$138
Akcea Therapeutics, Inc.
$134
Novo Nordisk Inc
$132
ATRICURE, INC.
$124
Philips North America LLC
$105
Lilly USA, LLC
$104
Medtronic USA, Inc.
$100
Sobi, Inc
$98
Bardy Diagnostics, Inc.
$95
CVRx, Inc.
$92
Kestra Medical Technology Services, Inc.
$73
Regeneron Healthcare Solutions, Inc.
$70
Kiniksa Pharmaceuticals International, plc
$68
Kowa Pharmaceuticals America, Inc.
$64
Bayer Healthcare Pharmaceuticals Inc.
$64
Bayer HealthCare Pharmaceuticals Inc.
$53
iRhythm Technologies, Inc.
$51
Daiichi Sankyo Inc.
$46
Merck Sharp & Dohme Corporation
$45
Celgene Corporation
$41
Astellas Pharma US Inc
$37
Cardiovascular Systems Inc.
$29
United Therapeutics Corporation
$27
BIOTRONIK INC.
$27
Otsuka America Pharmaceutical, Inc.
$25
Relypsa, Inc.
$21
Avion Pharmaceuticals
$16
HEARTFLOW, INC.
$15
Tactile Systems Technology Inc
$14
Preventice Services, LLC
$13
Siemens Medical Solutions USA, Inc.
$12
Top 3 companies account for 72.8% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (7999) SRC Undivided · (9266) ELCA · (P84) IGT Devices Systems · ACCOLADE SR · ACUSON SC2000 Diagnostic Ultrasound System · AMPLATZER · AMPLATZER TALISMAN · AMVUTTRA · AQUAMANTYS · ARCTIC FRONT ADVANCE · ASSURITY · ATRICLIP LAA EXCLUSION SYSTEM · AURORA EV-ICD MRI SURESCAN · AVEIR · AZURE XT DR MRI SURESCAN · Absorb GT1 · Advisa · Advisor Catheter · Ampere RF Ablation Generator · Amplia MRI · Arcalyst · Arctic Front · Assure WCD · Azure · BG Mini Plus · BRILINTA · Barostim Neo System · BodyGuardian · CAMZYOS · CARDIOBLATE CRYOFLEX · CARDIOMEMS · CARDIVA VASCADE 5F VCS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CONFIRM RX · CardioMEMS HF System · CareLink · Carnation Ambulatory Monitor · Carto 3 System · Confirm Rx · Corlanor · Diamondback Peripheral · ELIQUIS · EMBLEM · EMBLEM MRI S-ICD · ENDOTAK · ENSITE · ENSITE PRECISION · ENTRESTO · EP-WorkMate Claris System · EP-WorkMate Recording System · EPI-SENSE GUIDED COAGULATION SYS · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edora 8 DR-T · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · EnSite Precision Cardiac Mapping System · EnSite X · Ensite Cardiac Mapping System · Epi-Sense Guided Coagulation System with VisiTrax · FARXIGA · FFRct · FINELINE II Sterox · FLEXCATH ADVANCE · FLEXITOUCH · Fortify Assura · GALLANT · GENERAL BRADY · GENERAL TACHY · GENERAL THERAPIES · GENERAL EP · GENERAL TACHY · GENERAL THERAPIES · GENERAL - BRADY · GENERAL - TACHY · GENERAL - THERAPIES · GENERAL PAIN MANAGEMENT · GENERAL TACHY · General - Brady · General - Tachy · General - Therapies · INGEVITY · INJECTAFER · INTELLATIP · Inpefa · Inquiry EP Diagnostic Catheters · JARDIANCE · JOT DX · Kerendia · LATITUDE · LEQVIO · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · Leadless Pacemaker · Lexiscan · LifeVest · Livalo · MAESTRO 4000 · MICRA · MODELS · MOUNJARO · MULTAQ · Merlin Connectivity and Remote · Micra · Mitra Clip system · MitraClip System · Models · MyCareLink · NA · NEXLETOL · Nanostim Leadleas Pacemaker · Non-Franchise (NOF) - NonProduct · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · Optimizer · Ozempic · PASCAL · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PULSESELECT · Percepta · Prenate Mini · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · RELIANCE 4-FRONT · RESONATE · RESONATE EL ICD VR · RHYTHMIA · Repatha · Rhythmia Mapping System · Rybelsus · S ICD · S-ICD · S-ICD System Magnet · SAMSCA · SELECTSECURE · SENSOR ENABLED · SQ RX · SQ RX PULSE GENERATOR · SQ-RX PULSE GENERATOR · SQRX PULSE GENERATOR · Sentinel · TACTICATH ABLATION CATHETER · TEGSEDI · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TYRX · TYVASO · TactiCath Quartz CFA Catheter · Tendril Pacing Lead · UPTRAVI · Unify Assura CRT Defibrillator · VANTAGEVIEW · VERQUVO · VIEWMATE · VIGILANT · VIGILANT X4 CRT-D · VISIONIST CRT-P · VYNDAQEL · Vascepa · Veltassa · Visia AF · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WINREVAIR · XARELTO · ZEPBOUND · ZIO Patch · ZIO XT Patch · myLUX Patient Kit with mobile device · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (50%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for cardiovascular disease in CA.
Geographic Context
Cardiologists within 10 mi
590
Per 100K population
6.0
County median income
$87,760
Nearest hospital
GLENDALE ADVENTIST MEDICAL CENTER
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rashtian is a remote & electrophysiology specialist, with above-average Medicare volume (top 7% in CA), with speaking/promotional industry engagement in the top 3% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rashtian experienced with remote patient monitoring device, 30 days?
Based on Medicare claims data, Dr. Rashtian performed 1,040 remote patient monitoring device, 30 days services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rashtian receive payments from pharmaceutical companies?
Yes. Dr. Rashtian received a total of $220,798 from 61 companies across 1,577 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rashtian's costs compare to other cardiologists in Pasadena?
Dr. Rashtian's average Medicare payment per service is $112. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rashtian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Pasadena
Browse cardiologists in Pasadena ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology